Abiopharma

News list

Sheena Jonathan 🟡 adjusted position in 0 shares (1 derivative) of Natera, Inc. (NTRA) at $9.59 Transaction Date: Jan 05, 2026 | Filing ID: 000002

Full text

News bot Jan. 7, 2026, 2:07 a.m.
🔍 Sheena Jonathan (Executive)

Company: Natera, Inc. (NTRA)

Report Date: 2026-01-05
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 1
- Holdings reported: 2
- Total shares acquired: 39,615
- Total shares sold: 39,615
- Total shares held: 45,064
Detailed Transactions and Holdings:
- Acquired 39,615 shares of Common Stock at $9.59 per share (Direct)
  Date: 2026-01-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 262,581.00 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-05 | Code: H | nature_of_ownership: By Caraluna 1 Trust | shares_owned_after: 22,532.00
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-05 | Code: H | nature_of_ownership: By Caraluna 2 Trust | shares_owned_after: 22,532.00
- Sold 39,615 shares of Stock Option (right to buy) at $9.59 per share (Derivative)
  Date: 2026-01-05 | Code: M | Expires: 2026-04-07 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The option shares are fully exercisable.